Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
about
sameAs
Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspectsInfluence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis.Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor LigandsInvited review: the evolution of antidepressant mechanismsAcute D-serine treatment produces antidepressant-like effects in rodentsL-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications.Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies.Phosphodiesterase 4 inhibitors enhance sexual pleasure-seeking activity in rodents.LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response.Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression.From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies.Acute tryptophan depletion. Part I: rationale and methodology.The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder.Viral vector mediated expression of mutant huntingtin in the dorsal raphe produces disease-related neuropathology but not depressive-like behaviors in wildtype mice.Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.History of serotonin and serotinin disorders.Biochemistry of mental depression.New perspectives on the molecular pharmacology of affective disorders.Discovery and characterization of a novel tryptophan hydroxylase 1 inhibitor as a prodrug.The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study.Neurochemical mechanisms of mood stabilization. Focus on electroconvulsive therapy.Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase.Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.Clinical investigation of monoamine neurotransmitter interactions.[Biochemical research in depression (author's transl)].Refractory depression: the addition of lithium to fluoxetine or desipramine.Effect of selective monoamine oxidase inhibitors on rat pineal melatonin synthesis in vitro.Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.A pivotal role for serotonin (5HT) in the regulation of beta adrenoceptors by antidepressants: reversibility of the action parachlorophenylalanine by 5-hydroxytroptophan.Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.Exploring the effects of depression and treatment of depression in reinforcement learning.Strain differences in basal and post-citalopram extracellular 5-HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase-2 activity.Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in ratsEffects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.Strain-dependent serotonin neuron feedback control: role of serotonin 2C receptors.Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system.Blood serotonin and tryptophan in Tourette syndrome.
P2860
Q24629807-466D7282-827D-40B3-BE1C-FDDD53294D91Q26775107-14425646-EEF1-48B9-B77B-8D413E4FBE41Q26799334-A61CA822-7002-49AB-B539-098EFF85675EQ28241221-FC5C817C-9A9C-4BBD-9830-8A0C8E6588B7Q30505292-B1821BC9-3ACF-420A-A294-93297E9F9A64Q34011523-AB28E458-029A-4253-BCC5-7081D8A429C1Q34030711-26E1B6E3-8A82-4874-9945-FFE3F752A5CBQ34612909-4B09BD28-757D-4172-86E1-CDCA7D631468Q34728708-C6D18FFB-4419-47C7-9E90-390024D915B6Q34790812-8F3D0F2D-352D-48B6-B7B4-FCB3AA3A136FQ34982504-4851EC2B-D92B-45C0-860A-6252FECBCB45Q35161420-3077FE41-2F03-48D7-A22E-223431405B08Q35680852-51D99157-96EE-48F4-94F9-E32581AC5D35Q36106487-F79ABB0F-A283-4318-BE38-42E7B3E43BB7Q36183259-BE420293-00C0-4710-A098-100F2483AEE6Q36825752-5F564C56-18F4-41F4-8B66-B807FC5EDBE2Q37696661-A4D9459E-F464-488C-9795-AC19D383CEC6Q37954521-860B2BC6-350F-402E-B1FE-158EE4D09EFBQ38004411-C8F1AD2B-6EF6-4E01-9C53-B657B64246FDQ38065156-A48B7573-8F7E-4CA8-94FC-52B974081723Q38285581-B7EC421F-EBEB-4B96-9B93-4AD7FF17D75CQ38674006-3FFFE88F-744F-412E-BBBE-4E066A3E67F5Q39443227-377BDCB7-B297-4B99-9FD4-DE08E0584BA3Q39501585-C3089C0F-8BE8-4101-AB4B-897EF2D5FB90Q40143486-10A80EF8-735F-4CAE-9EE6-EC890BA3B374Q40181747-676D2C88-FF21-46DB-BF2D-5D1771D20584Q40576780-F525F964-0C65-410E-9F0F-B828BB6E8D75Q41028745-C75C8CE9-8D9B-41A2-849D-5E2303EA8B6DQ41162871-A8BF5C93-EAE5-45A9-82CE-CC141130CBA0Q41252647-C437750F-009F-496E-BD48-3362E694D8BAQ41346194-C4D388F4-AA82-4E61-9D7D-E89C306B2462Q41529804-F22076D1-DB1A-468E-9197-275F3BB07531Q41943320-36D3503F-7156-463E-A561-08EF3DD8B2B6Q41973918-5F474FEC-6E51-40AC-8890-202EA7371BF5Q42516758-388B247E-8CA3-4AD8-839A-F78D64300858Q42682244-EA67BE74-65B3-4100-9516-10B17F4F8A78Q42709994-D460821A-B1A6-42CE-9AE2-B08346F2A5B2Q43003243-4D05A104-8C72-4F93-B9DE-E5061FA82F7AQ44132538-D8514ECD-EC34-481B-B1E3-9B40929AF156Q44576590-FC3FAD5F-179E-4EA8-80E3-288E6633C764
P2860
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
description
1976 nî lūn-bûn
@nan
1976 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@ast
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@en
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@nl
type
label
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@ast
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@en
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@nl
prefLabel
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@ast
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@en
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@nl
P2093
P1433
P1476
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
@en
P2093
P356
10.1001/ARCHPSYC.1976.01770070041003
P407
P577
1976-07-01T00:00:00Z